Kurt M Eichler Form 4/A Spring Bank Pharmaceuticals / Kurt M Eichler ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Eichler Kurt M

(Last) (First) (Middle)

C/O SPRING BANK PHARMACEUTICALS, INC.

86 SOUTH STREET

(Street)

HOPKINTON MA 01748

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Spring Bank Pharmaceuticals, Inc. [ SBPH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
05/11/2016

4. If Amendment, Date of Original Filed (Month/Day/Year)
05/12/2016

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/11/2016		X		9,375	A	$8	9,375(1)	I	See Footnote(2)
Common Stock	05/11/2016		X		10,416	A	$9	19,791(3)(4)(5)	I	See Footnote(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The original filing on May 12, 2016 (SEC Accession No. 0000899243-16-019806) (the "Original Form 4") erroneously over-reported the total shares held following the transaction by 10,000 shares, and mistakenly indicated that such shares were directly held by Katherine Eichler and beneficially owned by the Reporting Person. The Original Form 4 is hereby amended to reflect that 9,375 shares were held directly by Teresa Eichler as custodian for Katherine Eichler UGMA NJ, and beneficially owned by the Reporting Person, on May 12, 2016 following the reported transaction.

2. These shares are directly held by Teresa Eichler as custodian for Katherine Eichler UGMA NJ. Teresa Eichler and Katherine Eichler are immediate family members sharing a household with the Reporting Person.

3. The Original Form 4 is hereby amended to delete the line items which appeared in Table I and Table II erroneously reporting that the Reporting Person was the indirect beneficial owner of 19,791 warrants, which were exercised for 19,791 shares of common stock of the Company, held directly by Pauline Eichler. The Reporting Person is not a beneficial owner of securities held by Pauline Eichler, with whom he does not share a household, nor was he at the time of the original filing.

4. The Original Form 4 is hereby amended to delete the line items which appeared in Table I and Table II erroneously reporting that the Reporting Person was the indirect beneficial owner of 19,791 warrants, which were exercised for 19,791 shares of common stock of the Company, held directly by Emerson Eichler. The Reporting Person is not a beneficial owner of securities held by Emerson Eichler, with whom he does not share a household, nor was he at the time of the original filing.

5. The Original Form 4 is hereby amended to delete the line items which appeared in Table I and Table II erroneously reporting that the Reporting Person was the indirect beneficial owner of 19,791 warrants, which were exercised for 19,791 shares of common stock of the Company, held directly by Lindsay Eichler. The Reporting Person is not a beneficial owner of securities held by Lindsay Eichler, with whom he does not share a household, nor was he at the time of the original filing.

Remarks:

	/s/Lori Firmani, attorney-in-fact	10/11/2016
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.